Recent Advances in Comprehending Endothelial Dysfunction and Diabetic Cardiomyopathy: From Molecular Mechanisms to Clinical Applications
Journal of Cardiovascular Development and Disease · 10.08.2026 · 13 (8) · 377
DOI: 10.3390/jcdd13080377 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 10.08.2026. Verfasst von Shengying Jia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Central Hospital of Dalian University of Technology, Dalian 116033, China. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Central Hospital of Dalian University of Technology ‘Climbing Plan’.
Abstract (Originalsprache)
Diabetic cardiomyopathy (DCM) is a cardiac condition characterized by various structural and functional abnormalities that are associated with diabetes mellitus. Its development involves multiple factors, among which endothelial dysfunction plays a significant role. To fully describe the relationship between DCM and endothelial dysfunction, we conducted a literature search across several databases, including PubMed, Web of Science, and EMBASE. Our review of DCM research focused on understanding its mechanisms, exploring the methods used to diagnose it, and potential treatment options. Although researchers have made significant progress in DCM diagnosis and treatment in recent years, considerable challenges persist as well. Artificial intelligence (AI)-based multimodal approaches may provide new opportunities for cardiovascular risk stratification and early DCM screening, but DCM-specific models still require external validation before clinical implementation. Regarding treatment options, emerging evidence suggests potential benefits of medications that enhance mitochondrial function and antioxidant properties, as well as anti-inflammatory therapies and lifestyle modifications. Future research should focus on combining different relevant data types, such as genetic and molecular information, to improve the AI tools utilized in medical environments. This study aims to identify novel markers for diagnosing DCM and to devise tailored treatment approaches. These advancements have the potential to improve the prognosis of DCM patients and enhance the identification and management of this condition.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Central Hospital of Dalian University of Technology, Dalian 116033, China.
- Department of Geriatrics, Chengdu Fifth People's Hospital Affiliated to Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
- Geriatric Diseases Institute of Chengdu, Chengdu 611137, China.
ORCID-Profile: Shengying Jia, Zuowei Pei
Förderung
- Central Hospital of Dalian University of Technology ‘Climbing Plan’
Zitieren
APA
Jia, S., Wang, L., & Pei, Z. (2026). Recent Advances in Comprehending Endothelial Dysfunction and Diabetic Cardiomyopathy: From Molecular Mechanisms to Clinical Applications. Journal of Cardiovascular Development and Disease, 13(8), 377. https://doi.org/10.3390/jcdd13080377
Vancouver
Jia S, Wang L, Pei Z. Recent Advances in Comprehending Endothelial Dysfunction and Diabetic Cardiomyopathy: From Molecular Mechanisms to Clinical Applications. Journal of Cardiovascular Development and Disease. 2026;13(8):377. doi:10.3390/jcdd13080377
BibTeX
@article{Jia2026,
author = {Jia, Shengying and Wang, Li and Pei, Zuowei},
title = {Recent Advances in Comprehending Endothelial Dysfunction and Diabetic Cardiomyopathy: From Molecular Mechanisms to Clinical Applications},
journal = {Journal of Cardiovascular Development and Disease},
year = {2026},
volume = {13},
number = {8},
pages = {377},
doi = {10.3390/jcdd13080377}
}
EUVIMED